Life Sciences

LIFE SCIENCES BY SIMON SILVER Department of Microbiology & Immunology University of Illinois Chicago, Ill. The protein secretory apparatus E. coli is being taken apart and put together in vitro like a Tinkertoy: SecA is a peripheral membrant ATPase of 102 kdaltons. SecB is separate and exists as a cytoplasmic tetramer of 16x4=64 kdaltons that is sufficient by itself for transport of some exported polypeptides. M. Watanabe, G. Blobel, “Cytosolic factor purified from Escherichia coli is

Written bySimon Silver
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BY SIMON SILVER
Department of Microbiology & Immunology
University of Illinois
Chicago, Ill.

The protein secretory apparatus E. coli is being taken apart and put together in vitro like a Tinkertoy: SecA is a peripheral membrant ATPase of 102 kdaltons. SecB is separate and exists as a cytoplasmic tetramer of 16x4=64 kdaltons that is sufficient by itself for transport of some exported polypeptides.

M. Watanabe, G. Blobel, “Cytosolic factor purified from Escherichia coli is necessary and sufficient for the export of a preprotein and is a homotetramer of SecB,” Proceedings of the National Academy of Sciences, USA, 86,2728-32, April 1989. (The Rockefeller University, New York, N.Y.)

K. Cunningham, R. Lill, E. Crooke, M. Rice, et al., “SecA protein, a peripheral protein of the Escherichia coli plasma membrane, is essential for the functional binding and translocation of proOmpA,” EMBO Journal, 8. 955-9, March 1989. (University of California, Los Angeles; State University ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies